{"transactions":[{"id":3054519,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2020-08-18T23:02:15.000Z","date":"2020-08-16","kind":"exercise","acquired":false,"shares":1595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date.  6.25% of the RSUs vested on August 16, 2020 and an additional 6.25% will vest in quarterly installments on the 16th day of each February, May, August and November thereafter, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date.  6.25% of the RSUs vested on August 16, 2020 and an additional 6.25% will vest in quarterly installments on the 16th day of each February, May, August and November thereafter, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date."}],"balance_after":23937,"derivative":{"underlying":"Common Stock","underlying_shares":1595},"source":{"system":"sec-edgar","filing":"0000899243-20-022790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320022790/doc4.xml","form_type":"4"}},{"id":3054518,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-08-18T23:02:15.000Z","date":"2020-08-16","kind":"tax_withholding","acquired":false,"shares":552,"price":28.53,"value":15748.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 1,595 shares of Common Stock underlying the Reporting Person's Restricted Stock Units."}],"balance_after":24615,"source":{"system":"sec-edgar","filing":"0000899243-20-022790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320022790/doc4.xml","form_type":"4"}},{"id":3054517,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-08-18T23:02:15.000Z","date":"2020-08-16","kind":"exercise","acquired":true,"shares":1595,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 733 shares acquired by the Reporting Person on August 14, 2020 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":25167,"source":{"system":"sec-edgar","filing":"0000899243-20-022790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320022790/doc4.xml","form_type":"4"}},{"id":3120653,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2020-06-05T23:57:51.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":25532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. In general, 6.25% of the RSUs will vest on August 16, 2020 and 6.25% will vest in quarterly installments on the 16th day of February, May, August and November, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. In general, 6.25% of the RSUs will vest on August 16, 2020 and 6.25% will vest in quarterly installments on the 16th day of February, May, August and November, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through the applicable vesting date."}],"balance_after":25532,"derivative":{"underlying":"Common Stock","underlying_shares":25532},"source":{"system":"sec-edgar","filing":"0000899243-20-015537","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320015537/doc4.xml","form_type":"4"}},{"id":3120652,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-05T23:57:51.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":183727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will vest over approximately four years. 1/48th of the shares of Common Stock underlying the Option will vest on a monthly basis after June 3, 2020 (the \"Vesting Commencement Date\"), such that all of the shares underlying the Option will be vested on the date four (4) years after the Vesting Commencement Date, subject to the Reporting Person's continued Service Relationship (as defined in the Plan) with the Issuer or any of its subsidiaries through the applicable vesting date."}],"balance_after":183727,"derivative":{"exercise_price":28.86,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":183727},"source":{"system":"sec-edgar","filing":"0000899243-20-015537","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320015537/doc4.xml","form_type":"4"}},{"id":3341082,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2019-12-17T02:05:12.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":72696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units are convertible to Common Stock on a 1 for 1 basis and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The units shall vest as to 25% of the units on February 16, 2021, and as to 1/12th of the units each quarter thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The units shall vest as to 25% of the units on February 16, 2021, and as to 1/12th of the units each quarter thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":72696,"derivative":{"underlying":"Common Stock","underlying_shares":72696},"source":{"system":"sec-edgar","filing":"0000899243-19-029354","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319029354/doc4.xml","form_type":"4"}},{"id":3369981,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2019-11-16T00:23:08.000Z","date":"2019-11-13","kind":"grant","acquired":true,"shares":106469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted Stock Units are convertible to Common Stock on a 1 for 1 basis and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The units shall vest as to 25% of the units on November 16, 2020, and as to 1/12th of the units each quarter thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units are convertible to Common Stock on a 1 for 1 basis and have no expiration date."}],"balance_after":106469,"derivative":{"underlying":"Common Stock","underlying_shares":106469},"source":{"system":"sec-edgar","filing":"0000899243-19-027434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319027434/doc4.xml","form_type":"4"}},{"id":3369980,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-16T00:23:08.000Z","date":"2019-11-13","kind":"grant","acquired":true,"shares":102081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable as to 25% of the shares on October 7, 2020, and as to 1/48th of the shares each month thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":102081,"derivative":{"exercise_price":26.28,"expiration_date":"2029-11-12","underlying":"Common Stock","underlying_shares":102081},"source":{"system":"sec-edgar","filing":"0000899243-19-027434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319027434/doc4.xml","form_type":"4"}},{"id":3369979,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-11-16T00:23:08.000Z","date":"2019-11-13","kind":"grant","acquired":true,"shares":22839,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22839,"source":{"system":"sec-edgar","filing":"0000899243-19-027434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319027434/doc4.xml","form_type":"4"}},{"id":3438226,"issuer":{"id":11437,"kind":"organization","name":"Activision Blizzard, Inc."},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Chief People Officer"}}],"security":"Employee Stock Options","published_at":"2019-08-15T19:06:49.000Z","date":"2019-08-13","kind":"exercise","acquired":false,"shares":134845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The exercised options vested on May 30, 2019. The remaining options vest on May 30, 2020, subject to Mr. Stolz's employment through that date."}],"balance_after":44948,"derivative":{"exercise_price":40.61,"expiration_date":"2026-08-08","underlying":"Common Stock, par value $0.000001 per share","underlying_shares":134845},"source":{"system":"sec-edgar","filing":"0001708989-19-000052","document":"wf-form4_156591039385055.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/718877/000170898919000052/wf-form4_156591039385055.xml","form_type":"4"}},{"id":3438225,"issuer":{"id":11437,"kind":"organization","name":"Activision Blizzard, Inc."},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Chief People Officer"}}],"security":"Common Stock, par value $0.000001 per share","published_at":"2019-08-15T19:06:49.000Z","date":"2019-08-13","kind":"sale","acquired":false,"shares":134845,"price":47.7976,"value":6445267.372,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price. The prices actually received for the stock ranged from $47.74 to $47.98 per share. Mr. Stolz has provided the Company, and upon request, will provide any security holder of the Company or the SEC staff, with information regarding the number of shares sold at each price within that range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the transactions reported on this Form 4, Mr. Stolz held (a) 40,955 shares of the Company's common stock and (b) 67,086 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock."}],"balance_after":108041,"source":{"system":"sec-edgar","filing":"0001708989-19-000052","document":"wf-form4_156591039385055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/718877/000170898919000052/wf-form4_156591039385055.xml","form_type":"4"}},{"id":3438224,"issuer":{"id":11437,"kind":"organization","name":"Activision Blizzard, Inc."},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Chief People Officer"}}],"security":"Common Stock, par value $0.000001 per share","published_at":"2019-08-15T19:06:49.000Z","date":"2019-08-13","kind":"exercise","acquired":true,"shares":134845,"price":40.61,"value":5476055.45,"ownership":{"direct":true},"balance_after":242886,"source":{"system":"sec-edgar","filing":"0001708989-19-000052","document":"wf-form4_156591039385055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718877/000170898919000052/wf-form4_156591039385055.xml","form_type":"4"}},{"id":3505839,"issuer":{"id":11437,"kind":"organization","name":"Activision Blizzard, Inc."},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock, par value $0.000001 per share","published_at":"2019-06-03T19:02:12.000Z","date":"2019-05-30","kind":"tax_withholding","acquired":false,"shares":36405,"price":43.56,"value":1585801.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 30, 2019, 77,360 performance-vesting restricted stock units held by Mr. Stolz vested. Pursuant to the terms of his restricted stock unit award agreement, the Company withheld 36,405 of the shares otherwise deliverable to him in order to satisfy the resulting tax withholding obligation. As the performance conditions underlying this restricted stock unit award were not achieved at the maximum level, 12,674 previously reported restricted stock units did not vest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the transaction reported on this Form 4, Mr. Stolz held (a) 40,955 shares of the Company's common stock and (b) 67,086 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock."}],"balance_after":108041,"source":{"system":"sec-edgar","filing":"0001708989-19-000016","document":"wf-form4_155960291735573.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718877/000170898919000016/wf-form4_155960291735573.xml","form_type":"4"}},{"id":3765938,"issuer":{"id":11437,"kind":"organization","name":"Activision Blizzard, Inc."},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock, par value $0.000001 per share","published_at":"2018-11-14T19:08:20.000Z","date":"2018-11-12","kind":"grant","acquired":true,"shares":11598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was for 11,598 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock. The number assumes maximum performance; target performance would result in a release of 9,278 shares of the Company's common stock. The restricted stock units vest in full on March 30, 2022, based upon the level of performance measured by reference to the Company's cumulative operating income for 2019, 2020 and 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the transactions reported on this Form 4, Mr. Stolz holds 157,120 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock."}],"balance_after":157120,"source":{"system":"sec-edgar","filing":"0001352027-18-000064","document":"wf-form4_154224048462938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718877/000135202718000064/wf-form4_154224048462938.xml","form_type":"4"}},{"id":4169681,"issuer":{"id":11437,"kind":"organization","name":"Activision Blizzard, Inc."},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock, par value $0.000001 per share","published_at":"2017-11-08T18:06:54.000Z","date":"2017-11-06","kind":"grant","acquired":true,"shares":10268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was for 10,268 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock. The number assumes maximum performance; target performance would result in a release of 8,214 shares of the Company's common stock. The restricted stock units vest in full on March 30, 2021, based upon the level of performance measured by reference to the Company's cumulative operating income for 2018, 2019 and 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the transactions reported on this Form 4, Mr. Stolz holds 145,522 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock."}],"balance_after":145522,"source":{"system":"sec-edgar","filing":"0001352027-17-000041","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718877/000135202717000041/edgar.xml","form_type":"4"}},{"id":4563175,"issuer":{"id":11437,"kind":"organization","name":"Activision Blizzard, Inc."},"owners":[{"id":147136,"kind":"person","name":"Stolz Brian M.","position":1,"cik":"0001524803","reported_name":"Stolz Brian M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock, par value $0.000001 per share","published_at":"2016-11-09T20:07:26.000Z","date":"2016-11-07","kind":"grant","acquired":true,"shares":15210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was for 15,210 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock. The number assumes maximum performance; target performance would result in a release of 12,168 shares of the Company's common stock. The restricted stock units vest in full on March 31, 2020, based upon the level of performance measured by reference to the Company's cumulative operating income for 2017, 2018 and 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the transactions reported on this Form 4, Mr. Stolz holds 135,254 performance-vesting restricted stock units, each representing the right to receive one share of the Company's common stock."}],"balance_after":135254,"source":{"system":"sec-edgar","filing":"0001352027-16-000122","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/718877/000135202716000122/edgar.xml","form_type":"4"}}]}